COVID-19 clinical outcomes in patients with and without ongoing therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
Author(s) -
Ahmed Nafakhi,
Ihsan S. Rabeea,
Rasha AlDarraji,
Hussein Nafakhi,
Ahmed Mechi,
Alhan Al-khalidi
Publication year - 2022
Publication title -
arterial hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.112
H-Index - 9
eISSN - 2449-6170
pISSN - 2449-6162
DOI - 10.5603/ah.a2022.0005
Subject(s) - medicine , angiotensin receptor blockers , case fatality rate , angiotensin converting enzyme , chest pain , adverse effect , statistical significance , intensive care unit , covid-19 , disease , blood pressure , epidemiology , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom